ANEB-001
ANEB-001 is an orally active CB1 inhibitor, can be used to research acute cannabinoid intoxication[1].
Product Specifications
CAS Number
[791848-71-0]
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/aneb-001.html
Purity
99.73
Solubility
10 mM in DMSO
Smiles
CC(C)(C)NC(N(C1)CC1O[C@H](C2=CC=C(C=C2)Cl)C3=C(C=CC=C3)C(F)(F)F)=O
Molecular Formula
C22H24ClF3N2O2
Molecular Weight
440.89
References & Citations
[1]Joseph Fenton Lawler, et al. Formulations and methods for treating acute cannabinoid overdose. US11141404B1
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CB1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1379823-01 0.02 mg (E-Coli)
Recombinant Sarcophaga peregrina AT-rich binding protein
Ask
View Details MBS1379823-02 0.02 mg (Yeast)
Recombinant Sarcophaga peregrina AT-rich binding protein
Ask
View Details